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Abstract 
A simple and alternative route to a versatile N-acetyl glucosamine disaccharide building block 
was developed, possessing a free 3-hydroxyl group. In this strategy, the 2,2,2-trichloro-ethoxy 
carbonyl (Troc) group was used as an amino- and 3-hydroxyl- protecting group. 
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Introduction 
 
Carbohydrates are the most abundant class of organic compounds in nature and have specific 
biological roles in living organisms.1 The vast majority of carbohydrates exist as 
polysaccharides, glycoconjugates or glycosides linked to other carbohydrate units or to 
aglycones via O-glycosidic bonds. The most important classes of oligoconjugates and naturally 
occurring oligosaccharides contain 2-amino-2-deoxysugar moieties, which are connected to other 
residues, commonly via a 1,2-trans-glycosidic linkage.2 Specifically, 2-N-acetamido-2-
deoxyglycosides, most frequently of D-glucose and D-galactose sequences, are found abundantly 
as glycoconjugates in living organisms. These 2-N-acetamido-2-deoxyglycosides contain 
glucosamine units which can be glycosylated through O-3, O-4, and O-6 positions.3 
2-Amino- sugars also play an important role on cell surfaces,1 and consequently are attractive 
targets for medicinal research. To investigate the biological activities associated with these 
oligosaccharides, isolation and purification of natural materials, in pure form, and in significant 
amount are required. Owing to the increasing interest in 2-amino- sugar oligosaccharides, special 
efforts have been dedicated to searches for efficient synthetic approaches to such complex 
molecules involving efficient, simple, region- and stereo- selective methods.2 To date, one of the 
most efficient strategies to prepare oligosaccharides consists in the preparation of key building 
blocks of di-, tri-, and higher- oligosaccharides, that can be further used to assemble larger 
molecules.3 
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Our group has focused on the development of straightforward routes to glucosamine 
disaccharides.4 Properly functionalized glucosamine disaccharides constitute key scaffolds in the 
synthesis of complex and biologically important oligosaccharides, such as the bacterial 
peptidoglycan unit (A),5 or for the preparation of branched tetrasaccharides (B),6 which are 
useful for the development of new anti-tumor therapies (Figure 1). 
 
 
 
Figure 1. Examples of biologically important oligosaccharides. 
 
Recently, we have explored a new synthetic strategy towards O-3- hydroxyl- free N-acetyl 
glucosamine disaccharides. We envisaged that a properly functionalized glucosamine 
disaccharide would allow further functionalization at O-3, such as regioselective glycosylation or 
lactate insertion. Also, the chosen substitution pattern would chemically differentiate the two 
glucosamine units, allowing the preparation of branched oligosaccharides as shown in Figure 2. 
 
 
 
Figure 2. Proposed disaccharide substitution pattern. 
 
The preparation of monomeric building blocks, donors and acceptors, commonly requires the 
manipulation of several protecting groups. Despite the stereoselective formation of the 
glycosydic bond, special attention has been given to the selective protection- and deprotection- 
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strategy and to the use of suitable protecting groups.7 In general, a standard strategy demands the 
use of robust protecting groups that survive various reaction conditions in multi-step sequences. 
The deprotection steps must occur under mild conditions and be performed in the presence of 
other functional groups. Therefore, it is highly desirable to develop new synthetic routes 
involving as few functional- group manipulations as possible. 
 
 
Results and Discussion 
 
The first step relied on the choice of the nitrogen protecting group for donor- and acceptor- 
moieties. It is well known that N-Troc (2,2,2-trichloro-ethoxy carbonyl)- glucosamine donors- 
and acceptors are more reactive than the corresponding N-Phth  glucosamines.8 The Troc group 
also gives higher β-selectivities than other groups.9 Also, the Troc group as an N-protecting 
group enhances glucosamine-4-hydroxy- acceptor reactivity when compared to other N-
protecting groups,10 and can be removed under mild conditions.11 On the other hand, a limited 
number of O-protecting groups has been reported in approaches developed towards N-Troc 
glucosamine units possessing an O-3 hydroxyl- group masked: Fmoc (9-fluorenylmethyl 
carbonate),12 Cbz (carbobenzyloxy),13 Ac (acetyl)14 and Troc.15 However, the Troc group has 
been scarcely used as an O-protecting group, and has only recently been reported in N-Troc 
glucosamine15a glycosyl units. 
We therefore selected Troc as an amine- protecting group for both an acceptor and donor. 
Particularly, in the case of the acceptor, the Troc group was also chosen to temporarily mask the 
O-3. This would allow protecting group removal under mild conditions, in a more advanced 
stage of the synthesis, in order to afford, after selective N-acetylation, a free hydroxyl group at 
O-3 at the final N-acetyl glucosamine disaccharide. 
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Scheme 1. Synthesis of the glucosamine acceptor. 
 
The synthesis started with the acceptor preparation (Scheme 1). Although the allyl ether has 
been frequently used as an anomeric protecting group, the benzyl group was chosen as an 
anomeric protecting group to avoid the use of expensive metal catalysts frequently employed in 
deallylation procedures.16 Thus, benzylation of N-Acetyl glucosamine (1) afforded 2,17 and 
subsequent replacement of the N-acetyl group by the N-Troc group gave 3 in 69% yield. The 
next step consisted in the arylidene- acetal formation to give 4 in 62% yield, followed by 
protection of the O-3 position with a Troc group, to afford 5 in 61% yield. Although 4 has 
already been prepared by a different route,18 our protocol allows an easier manipulation of the 
sequence intermediates, while avoiding the use of excess benzaldehyde and HCl. 
The selective benzylidene acetal ring opening was achieved by reductive ring- opening using 
triethylsilane and BF3.OEt2, and the acceptor 6 was isolated in 63% yield. 
The preparation of the donor moiety was carried out using a simple sequence starting from D-
glucosamine hydrochloride (7) (Scheme 2). Thus, N-Troc-1,3,4,6-O-tetra-acetyl glucosamine (8) 
was isolated in 85% yield after two steps.19 Selective removal of the anomeric acetyl group was 
performed by using morpholine, and after an acidic work-up and column chromatography9 was 
isolated in 79% yield.19 Treatment of 9 with CCl3CN and Cs2CO3 afforded the desired glycosyl 
trichloro- acetamidate 1020 in quantitative yield. 
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Scheme 2. Synthesis of the glucosamine donor. 
 
With the glucosamine acceptor, 6, and donor, 10, in hand, the next stage consisted in the 
glycosylation reaction. Thus, several experiments were carried to improve the yield of the 
glycosylation reaction, and several donor/acceptor ratios were investigated. The best results were 
obtained, under standard glycosylation conditions, when a 2:1 donor/acceptor ratio was used, and 
the desired β(1-4) glycoside 11 could be isolated in 40% yield. However, when the donor molar 
ratio increased, undesired side products were formed. 
The next step consisted in the removal of the three trichloro-ethyl carbamate protective 
groups, which was achieved by treatment of 11 with freshly activated zinc in acetic acid. 
Selective N-acetylation was performed using Ac2O in methanol, and the N-acetyl glucosamine 
disaccharide 12, possessing a free 3-OH, was isolated in 50% yield (Scheme 3). 
 
 
 
General Papers  ARKIVOC 2012 (vi) 90-100 
Page 95 ©ARKAT-USA, Inc. 
O
TrocHN
TrocO
OBn
HO O
TrocHN
AcO
OAc
AcO O
6
.
OBn
CCl3
NH
10
O
TrocHN
TrocO
OBn
O
.
OBn
O
TrocHN
AcO
OAc
AcO
11
O
AcHN
HO
OBn
O
.
OBn
O
AcHN
AcO
OAc
AcO
12a) TMSOTf, CH2Cl2, 3A MS, 20 min, -15 ºC; b) Zn, ACOH, RT, 12 h;
c) Ac2O, MeOH, 24 h.
+
a
b, c
 
 
Scheme 3. Glycosylation and Troc group removal. 
 
The disaccharide 12 constitutes a valuable intermediate for peptidoglycan fragments 
assembly. It is well known that in peptidoglycan synthesis, manipulation of the muramic acid 
building blocks can occur with side-reactions on the (R)-lactyl moiety, such as racemization, or 
intramolecular lactonization at O-4.21 Thus, with our approach the lactate insertion can be 
performed in a later stage of the synthesis, with the N-acetyl group already installed. Moreover, 
some difficulties are reported regarding the low nucleophilicity associated with the O-4 
position,22 and some methods have been reported to overcome this problem, such as the use of 
the oxazolidine group.9 The approach presented herein uses the Troc group as an amino group 
with the advantage of guaranteeing the β-stereoselectivity at the glycosylation step, as well as 
Troc as an O-3 protecting group due to its easy removal in a one-pot procedure, at an advanced 
stage of the synthesis. 
Additionally, the disaccharide 12 can be suitable for the preparation of glycoconjugates that 
contain N-acetylglucosamine and that glycosylate at O-3 and O-4, and allows an easy access to 
regioselective glycosylation at O-3 with other carbohydrate units (glucose, galactosamine).6 
 
 
Conclusions 
 
In summary, the use of two different substitution patterns for acceptor- and donor-, benzyl- and 
acetyl- groups, respectively, permits manipulation of the two units of the disaccharide 
independently by simply protecting- group removal. The protecting groups used are simple to 
remove, and all the steps involved in this route were performed under mild conditions, and 
avoided expensive reagents. The disaccharide 12 is a key scaffold for the preparation of several 
N-acetyl glucosamine derivatives useful for medicinal research, such as cancer diseases. Overall, 
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this constitutes a simple and alternative route to a versatile glucosamine disaccharide building 
block. 
 
 
Experimental Section 
 
General. Melting points were recorded on a Reichert-Thermovar hot stage apparatus and are 
uncorrected. Ordinary mass spectra were recorded on a Fisons Trio or an AEI MS-9 
spectrometer. High resolution mass spectra were recorded on an AutoSpeQ spectrometer. 1H and 
13C NMR spectra were recorded in CDCl3 on a Bruker ARX 400 spectrometer (400 MHz for 1H 
and 100.63 MHz for 13C). Chemical shifts reported are relative to tetramethylsilane as the 
internal reference (1H 0.00) for. 1H NMR spectra and to CDCl3 (13C 77.00) for 13C NMR spectra. 
Chemical shifts are expressed in parts per million downfield from TMS (δ=0) or residual 
dichloromethane (1H=5.32, 13C=53.1) as internal standards. IR spectra were run on Perkin– 
Elmer 683- and Spectrum 1000- instruments with absorption frequencies expressed in reciprocal 
centimeters. All reagents and solvents were purified and dried by standard methods23 before use. 
The term “usual work-up” implies that organic extracts were washed with water and dried over 
anhydrous sodium sulfate or magnesium sulfate, filtered, and solvent removed from the filtrate 
under reduced pressure. Analytical thin-layer chromatography and preparative TLC (PTLC) 
were performed on E. Merck Kieselgel 60, F254 silica gel (0.2 mm thick), or 0.5-, 1- or 2- mm 
thick plates (20x20 cm), respectively. Column chromatography was performed on E. Merck 
Kieselgel 60 (240–400 mm) silica gel. “RT” denotes room temperature. 
 
Benzyl 2-deoxy-2-(2,2,2-trichloro-ethoxycarbonylamino)-α-D-glucopyranoside (3).18 To a 
solution of N-Acetyl-glucosamine 1 (3 g, 13.5 mmol) and benzyl alcohol (22 mL) in toluene (36 
mL), was added p-toluenesulfonic acid monohydrate (0.15 g, 1.15 mmol). The reaction mixture 
was refluxed in a Dean–Stark apparatus with water- removal by the azeotrope mixture. After 5 h 
the reaction mixture was cooled to RT and a saturated solution of sodium bicarbonate was added. 
Toluene was removed under reduced pressure and diethyl ether: n-hexane (2:1, 80 mL) was 
added and stirred vigorously for 3 h. The light brown- colored precipitate was filtered off, 
washed with ether, and the crude product was recrystallized from ethanol to give a light brown 
solid, 2, in (2.1 g, 50% yield).17 The compound 2 was dissolved in 40 mL of ethanol, KOH (12.0 
g) was added, and the mixture heated at reflux under N2 overnight. The flask was cooled in an 
ice bath and the mixture neutralized with concentrated HCl. The precipitate formed was filtered 
off, washed with ethanol, and the ethanol layer concentrated. The residue obtained was dissolved 
in H2O (20 mL), and NaHCO3 (2 g) was added at 0 oC. TrocCl (1.2 mL, 9 mmol) was added 
dropwise and the mixture stirred for 2 h, warmed to RT, and stirred overnight. The crude 
material was neutralized with 1N HCl and the resulting white precipitate was filtered off, washed 
with water (2×10 mL) and ether (2×10 mL), and vacuum- dried. The compound obtained was 
recrystallized from ethanol and identified as 3, a white solid (2.0 g) in 69% yield, m.p. 85-87 °C; 
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[δ]D25 +100° (c 1, MeOH). 1H NMR (400 MHz, CDCl3+DMSO-d6, 23 °C): δH 7.14 (5H, m, ArH), 
5.88 (1H, d, J = 6.7 Hz, NH), 4.83 (1H, s, H-1), 4.61 (1H, d, J = 12 Hz, CH2CCl3), 4.54 (1H, d, J 
= 11.8 Hz, CH2Ph), 4.43 (1H, d, J = 12 Hz, CH2CCl3), 4.28 (1H, d, J = 11.8 Hz, CH2Ph), 3.48-
3.27 (6H, m,H-2, H-4. H-5, H-3,H-6a, H-6b). 13C NMR (100 MHz, CDCl3 + DMSO-d6, 23 °C): 
δc 55.3, 61.3, 68.8, 70.5, 71.1, 71.6,  73.9, 95.2, 96.1, 127.3, 127.4, 127.9, 136.8, 154.2. 
 
Benzyl 4,6-O-benzylidene-2-deoxy-2-(2,2,2-trichloro-ethoxycarbonylamino)-α-D-gluco-
pyranoside (4). To a solution of 3 (400 mg 0.90 mmol) in CH3CN (1.3 mL), were added CSA 
(41 mg, 0.17 mmol) and benzaldehyde dimethylacetal (243 µL, 1.59 mmol) and the mixture 
stirred at RT for 24 h. Then Et3N (0.5 mL) was added, the reaction mixture azeotroped with 
toluene, and the resulting crude material was kept under high vacuum for 2h. The residue was 
purified by silica-gel flash chromatography using chloroform: ethyl acetate (10:1). The product 
was identified as 4, a white solid, 297 mg (62%) yield, m.p. 154-157 °C.18 [δ]D22 +68.7° (c 1, 
CHCl3). 1H NMR (400 MHz, CDCl3, 23 °C): δH 7.50-7.36 (10H, m, ArH), 5.54 (1H, s, CHPh), 
5.31 (1H, d, J = 7.9 Hz, NH), 4.97 (1H, s, 1-H), 4.81 (1H, d, J = 11.8 Hz, CH2Ph), 4.74 (1H, d, J 
= 11.6 Hz, CH2CCl3), 4.64 (1H, d, J = 11.8 Hz, CH2Ph), 4.51 (1H, d, J = 11.6 Hz, CH2CCl3), 
4.26-4.23 (1H, m, H-2), 3.93-3.72 (4H, m, H-5, H-3, H-6a, H-6b), 3.57 (1H, t, J = 8.6 Hz, H-4), 
2.75 (1H, s, OH). 13C NMR (100 MHz, CDCl3, 23 °C): δc 55.6, 62.7, 68.7, 69.9, 74.7, 81.8, 95.3, 
97.1, 101.9, 126.2, 128.1, 128.3, 128.6, 129.3, 136.5, 136.9, 154.7; HR-MS (FI): m/z 531.0607 
(Calc. for C23H24Cl3NO7, 531.0618). 
 
Benzyl 2-deoxy-4,6-O-benzylidene-3-O-(2,2,2-trichloro-ethoxycarbonyl)-2-(2,2,2-trichloro-
ethoxycarbonylamino)-α-D-glucopyranoside (5). To compound 4 (400 mg, 0.75 mmol) in 
pyridine (1.5 mL), was added TrocCl (171 µL, 1.25 mmol), at 0 °C, and the solution stirred at 
RT for 12 h. The reaction mixture was azeotroped with toluene, and the residue purified by silica 
gel column chromatography using n-hexane: ethyl acetate (10:2), and the product identified as 5. 
This is a colorless solid, yield, 324mg (61%), m.p. 123-124 °C; [δ]D25 +35.2° (c 0.2, CHCl3). 1H- 
NMR (400 MHz, CDCl3, 23 °C): δH 7.43-7.32 (10H, m, ArH), 5.54 (1H, s, CHPh,), 5.27 (1H, d, 
J = 10 Hz, NH), 5.25 (1H, t, J = 10 Hz, 3-H), 4.99 (1H, d, J = 3.7 Hz, 1-H), 4.80-4.70 (4H, m, 
CH2Ph, CH2CCl3), 4.64 (1H, d, J = 12 Hz, CH2CCl3), 4.54 (1H, d, J = 11.7 Hz, CH2Ph), 4.21 
(1H, dd, J = 4.8 Hz, J = 4.8 Hz, H-6b,), 4.13-4.00 (1H, m, H-2), 3.93-3.86 (1H, m, H-5), 3.75-
3.70 (2H, m, H-4, H-6a). 13C NMR (100 MHz, CDCl3, 23 °C): δc 54.2, 63.0, 68.6, 70.1, 74.6, 
75.2, 76.3, 78.8, 94.3, 95.2, 97.0, 101.5, 126.1, 128.1, 128.3, 128.4, 128.7, 129.1, 136.1, 136.6, 
154.1; HR-MS (FI): m/z 704.9661 (Calc. for C26H25Cl6NO9, 704.9660). 
 
1,6-Di-O-benzyl-2-deoxy-3-O-(2,2,2-trichloro-ethoxycarbonyl)-2-(2,2,2-trichloro-ethoxy-
carbonylamino)-α-D-glucopyranoside (6). To a solution of 5 (800 mg, 1.12 mmol) in 13mL 
dry CH2Cl2, was added triethylsilane (1mL, 6.2 mmol), then BF3.OEt2 (148 µL, 1.17mmol) was 
slowly added. The reaction mixture was stirred for 3 h, until the reductive opening of the 
benzylidene ring was complete (confirmed by TLC). The reaction mixture was then diluted with 
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CH2Cl2. A saturated aqueous solution of NaHCO3 was added, extracted with CH2Cl2, and 
washed with brine. The organic layer was dried over anhydrous MgSO4 and the solvent removed 
under reduced pressure. The crude was purified by silica gel flash chromatography (ethyl acetate: 
n-hexane, 2:3) and identified as 6, a viscous liquid (505 mg, yield 63%). [δ]D25 +35.2° (c 0.5, 
CHCl3). 1H NMR (400 MHz, CDCl3, 23 °C): δH 7.36-7.33 (10H, m, ArH), 5.30 (1H, d, J = 9.4 
Hz, NH), 5.06-4.96 (2H, m, H-1, H-3), 4.87-4.51 (8H, m, 2xCH2CCl3, 2xCH2Ph), 4.11-4.06 (1H, 
m, H-2), 3.92-3.66 (4H, m, H-4, H-5, H-6), 2.75 (1H, s, OH). 13C NMR (100 MHz, CDCl3, 23 
°C): δc 53.6, 69.5, 69.7, 69.9, 70.0, 70.1, 73.7, 74.5, 76.9, 78.7, 94.2, 95.2, 96.5, 127.7, 127.7, 
128.2, 128.5, 128.6, 136.4, 137.4, 154.1, 154.4; HR-MS (FI): m/z 706.9817 (Calcd for 
C26H27Cl6NO9, 706.9817 ). 
Compounds 8, 9 and 10 were prepared according to the literature procedures;11a,19 however, 
instead of K2CO3, Cs2CO3 was used for the preparation of 10. 
 
1,6-Di-O-benzyl-4-O-[3,4,6tri-O-acetyl-2-deoxy-2-(2,2,2-trichloro-ethoxycarbonylamino)-β-
D-glucopyranosyl]-3-O-(2,2,2-trichloro-ethoxycarbonyl)-2-deoxy-2-(2,2,2-trichloro-ethoxy-
carbonylamino)-α-D-glucopyranoside (11). To a solution of the donor 10 (353 mg, 0.56 
mmol), and acceptor 6 (200 mg, 0.28 mmol), with 3Å molecular sieves in dry CH2Cl2 (11 mL) at 
-15 °C, was added TMSOTf (15 µL, 0.084 mmol). After stirring for 20 min, the reaction was 
quenched with a cold saturated aqueous solution of NaHCO3 (1.5 mL), and extracted with CHCl3 
(10 mL). The organic layer was washed with saturated aqueous NaHCO3 (4 mL) and brine (2 
mL), dried over anhydrous Na2SO4, and the organic layer concentrated under reduced pressure. 
The residue was purified by silica-gel flash chromatography with toluene:acetone (10:1) and 
identified as 11, a colorless solid (132mg), in 40% yield, m.p. 186-189 °C. [δ]D25 +35.2° (c 0.5, 
CHCl3). 1H NMR (400 MHz, CDCl3, 23 °C): δH 7.54-7.25 (10H, m, ArH), 6.57 (1H, brs, NH), 
5.75 (1H, brs, NH), 5.22-4.49 (13H, m, CH2Ph, 3xCH2CCl3, H-1, H-2, H-2’, H-1’, H-3’), 4.34 
(2H, d, J = 8 Hz, CH2Ph ), 4.09-3.92 (4H, m, H-3, H-6, H-5’, H-4’), 3.75-3.44 (5H, m, H-6’, H-
6, H-4, H-5), 2.10 (3H, s, CH3CO), 2.01 (3H, s, CH3CO), 1.98 (3H, s, CH3CO). 13C NMR (100 
MHz, CDCl3, 23 °C): δc 20.6, 20.8, 54.0, 55.6, 62.3, 66.4, 68.7, 69.9, 70, 70.1, 73.5, 74.5, 74.7, 
76.5, 77.1, 91.7, 94.5, 95.5, 96.2, 97.5, 128.2, 128.3, 128.6, 129.1, 129.4, 129.6, 136.4, 137.4, 
153.7, 154; MALDI-TOF: m/z 1195.142 (1194.970 calculated for C41H45Cl9N2NaO18). 
1,6-Di-O-benzyl-4-O-[3,4,6-tri-O-acetyl-2-acetamido-β-D-glucopyranosyl]-2-acetamido-α-
D-glucopyranoside (12). To a solution of 11 (40 mg, 0.03 mmol) in freshly activated zinc dust 
(28 mg) and acetic acid (0.76 mL, 13 mmol), and the mixture was stirred overnight. The progress 
of the reaction was monitored by TLC using CHCl3:MeOH (10:1). After completion of the 
reaction, the mixture was filtered over Celite, washed with ethyl acetate, azeotroped with 
toluene, and concentrated under reduced pressure. The residue was dissolved in MeOH (40 µL), 
then Ac2O (28 mg, 0.27 mmol) was added and the resulting mixture stirred overnight. The 
mixture was filtered off and washed with ethyl acetate, azeotroped with toluene, and 
concentrated under reduced pressure. The residue was purified by column chromatography using 
toluene:acetone (10:1) and identified as 12, a viscous liquid (12 mg, 50% yield). 1H NMR (400 
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MHz, CDCl3, 23 °C): δH 7.41-7.25 (m, 10H), 6.38 (brs, 1H), 5.62 (d, 1H, J = 8.8 Hz), 4.98- 4.49 
(m, 6H), 4.34-4.10 (m, 5H), 3.97-3.52 (m, 8H), 2.10-2.06 (m, 9H), 1.98 (s, 3H), 1.87 (s, 3H). 
MALDI-TOF: 751.337 [M-2] Calculated for C36H46N2NaO14 (753.284). 
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